375 related articles for article (PubMed ID: 26218904)
1. M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
Zhou Y; Yoshida S; Nakao S; Yoshimura T; Kobayashi Y; Nakama T; Kubo Y; Miyawaki K; Yamaguchi M; Ishikawa K; Oshima Y; Akashi K; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4767-77. PubMed ID: 26218904
[TBL] [Abstract][Full Text] [Related]
2. Macrophages promote vasculogenesis of retinal neovascularization in an oxygen-induced retinopathy model in mice.
Gao X; Wang YS; Li XQ; Hou HY; Su JB; Yao LB; Zhang J
Cell Tissue Res; 2016 Jun; 364(3):599-610. PubMed ID: 26841878
[TBL] [Abstract][Full Text] [Related]
3. The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization.
Kataoka K; Nishiguchi KM; Kaneko H; van Rooijen N; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1431-8. PubMed ID: 21051720
[TBL] [Abstract][Full Text] [Related]
4. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
5. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
6. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
7. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
Scott A; Powner MB; Fruttiger M
Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
[TBL] [Abstract][Full Text] [Related]
8. Spatial distribution of CD115
Brockmann C; Dege S; Crespo-Garcia S; Kociok N; Brockmann T; Strauß O; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):313-323. PubMed ID: 29185100
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
10. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
11. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
12. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.
Chu ZJ; Dou GR; Wang YS; Qu XJ; Zhang Y
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1937-43. PubMed ID: 23740517
[TBL] [Abstract][Full Text] [Related]
14. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Fang X; Ueno M; Yamashita T; Ikuno Y
Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.
Li Z; He T; Du K; Xing YQ; Yan Y; Chen Z; Zhang H; Shen Y
Mol Vis; 2012; 18():2847-59. PubMed ID: 23233787
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.
Zou J; Tan W; Li B; Wang Z; Li Y; Zeng J; Jiang B; Yoshida S; Zhou Y
Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):9. PubMed ID: 35816041
[TBL] [Abstract][Full Text] [Related]
17. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.
Cheng G; Tian K; Zhang L; Yang N; Xing Y; He T
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):97-108. PubMed ID: 26358273
[TBL] [Abstract][Full Text] [Related]
18. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N; Krohne TU; Poulaki V; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
[TBL] [Abstract][Full Text] [Related]
20. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
